B. Francis

发表

[125I]17-α-Iodovinyl 11-β-Methoxyestradiol Interaction in Vivo with Estrogen Receptors in Hormone-independent MCF-7 Human Breast Cancer Transfected with the v-rasH Oncogene

S. Larson, R. Reba, M. Lippman, 1987 .

The plasma–occupancy relationship of the novel GABAA receptor benzodiazepine site ligand, α5IA, is similar in rats and primates

G. Dawson, J. Atack, R. Hargreaves, 2009, British journal of pharmacology.

RESEARCH PAPER The plasma-occupancy relationship of the novel GABAA receptor benzodiazepine site ligand, a5IA, is similar in rats and primates

G. Dawson, H. Burns, J. Atack, 2009 .

In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha1A-adrenoceptor antagonist.

M. Bock, R. Chang, B. Lagu, 2000, European journal of pharmacology.

In vivo competition studies with analogues of 3-quinuclidinyl benzilate.

R. Reba, W. Eckelman, J. Conklin, 1984, Journal of pharmaceutical sciences.

The use of tritium labeled compounds to develop gamma-emitting receptor-binding radiotracers.

R. Reba, W. Eckelman, B. Francis, 1982, International journal of nuclear medicine and biology.

Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents

D. Macintyre, L. V. D. van der Ploeg, L. Shearman, 2007, Journal of Pharmacology and Experimental Therapeutics.

Quality control procedure for 6-[18F]fluoro-L-DOPA: a presynaptic PET imaging ligand for brain dopamine neurons.

R. Cohen, R. Finn, B. Francis, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Characterization of specific binding of [125I]L-762,459, a selective alpha1A-adrenoceptor radioligand to rat and human tissues.

R. Chang, H. Burns, B. Francis, 1998, European journal of pharmacology.

Radioiodinated endothelin-1: a radiotracer for imaging endothelin receptor distribution and occupancy.

H. Burns, B. Francis, R. Gibson, 1999, Nuclear medicine and biology.

Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis.

B. Francis, R. Gibson, P. Siegl, 1993, Thrombosis research.

Kinetic Analysis of 3-Quinuclidinyl 4-[125] Iodobenzilate Transport and Specific Binding to Muscarinic Acetylcholine Receptor in Rat Brain In Vivo

S. Larson, C. Patlak, K. Pettigrew, 1989 .

Binding Characteristics and Biological Activity of 17α-[125I]Iodovinyl-11β-methoxyestradiol, an Estrogen Receptor-binding Radiopharmaceutical, in Human Breast Cancer Cells (MCF-7)

S. Larson, R. Reba, W. Eckelman, 1986 .

Synthesis of a 11C-labeled novel, quinuclidine based ligand for the 5-HT3 receptor

M. Diksic, H. Burns, B. Francis, 1992 .

Synthesis and evaluation of radioiodinated derivatives of 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(4-iodophenyl)-alpha- phenylacetate as potential radiopharmaceuticals.

R. Reba, W. Eckelman, J. Conklin, 1984, Journal of medicinal chemistry.

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

J. Metzger, D. Macintyre, R. Hargreaves, 1996, Neuropharmacology.

[125I] 3-quinuclidinyl 4-iodobenzilate: a high affinity, high specific activity radioligand for the M1 and M2-acetylcholine receptors.

R. Reba, W. Eckelman, E. Jagoda, 1984, Life sciences.

Effects of mutations at conserved TM II residues on ligand binding and activation of mouse 5-HT6 receptor.

B. Francis, Richard Z. Chen, L. Lin, 2006, European journal of pharmacology.

Synthesis and evaluation of (17 alpha,20E)-21-[125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17 -diol and (17 alpha,20E)-21-[125I]iodo-11 beta-methoxy-19-norpregna-1,3,5(10),20-tetraene-3,17-diol (17 alpha-(iodovinyl)estradiol derivatives) as high specific activity potential radiopharmaceuticals.

W C Eckelman, R E Gibson, R C Reba, 1984, Journal of medicinal chemistry.

[I-125] 17α-Iodovinyl 11β-Methoxyestradiol: In Vivo and In Vitro Properties of a High-Affinity Estrogen-Receptor Radiopharmaceutical

R. Reba, W. Eckelman, E. Jagoda, 1984 .

[77Br]-17-alpha-Bromoethynylestradiol: in vivo and in vitro characterization of an estrogen receptor radiotracer.

R. Reba, S. Wilbur, W. Eckelman, 1982, International journal of nuclear medicine and biology.

Kinetic Analysis of 3-Quinuclidinyl 4-[125I]Iodobenzilate Transport and Specific Binding to Muscarinic Acetylcholine Receptor in Rat Brain in vivo: Implications for Human Studies

S. Larson, C. Patlak, K. Pettigrew, 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development.

H. Burns, B. Francis, T. Hamill, 1999, Current opinion in chemical biology.

In vivo receptor binding of iodinated beta-adrenoceptor blockers.

R. Reba, W. Eckelman, B. Francis, 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Receptor-binding radiotracers: a class of potential radiopharmaceuticals.

W C Eckelman, R E Gibson, R C Reba, 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radioiodinated estrogen derivatives.

R. Reba, W. Eckelman, B. Francis, 1980, Journal of Nuclear Medicine.

No‐carrier‐added bromination of estrogens with chloramine‐t and Na77Br

J. W. Barnes, R. Reba, W. Eckelman, 1981 .

Radioiodinated L-703,606: a potent, selective antagonist to the human NK1 receptor.

H. Burns, B. Francis, C. Swain, 1994, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracer.

R. Reba, W. Eckelman, B. Francis, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Application of Organosilicon Chemistry to the Synthesis of Gamma and Positron Emitting Radiotracers for Use in Nuclear Imaging Studies

H. Burns, B. Francis, W. Eng, 1991 .

A kinetic comparison of [18F]2-fluoro-2-deoxyglucose and [18F]2-fluoro-2-deoxymannose using positron emission tomography.

P. Herscovitch, R. Finn, B. Francis, 1994, Nuclear medicine and biology.